Back
to sessions
Sep 30
Quick Pitch
Credits
| AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
09:00am - 09:05am ETSpeaker: Kent Mouw, MD, PhD - Dana-Farber Cancer Institute, Boston
-
09:05am - 09:10am ETSpeaker: Rongli Xu, MD - State Key Laboratory of Molecular Oncology and Department of Radiation Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Science, Beijing
-
09:10am - 09:15am ET
AKR1C3 Negatively Regulates the LGALS3/p62/NRF2 Axis to Inhibit Ferroptosis and Induce Radioresistance in Prostate Cancer
Speaker: Feng Lyu, MD, PhD - Peking University First Hospital, Beijing -
09:15am - 09:20am ET
Radiation Enhances Efficacy of Trastuzumab Deruxtecan in HER2-Low Metastatic Breast Cancer via HER2 Upregulation
Speaker: Qing Li, MD, PhD - UH Cleveland Medical Center, Cleveland -
09:20am - 09:25am ET
Nanoray Pancreas: Biomarker Insights of NBTXR3 Activated by Radiotherapy (RT) for Locally Advanced or Borderline Resectable Pancreatic Cancer (LAPC or BRPC)
Speaker: Kasey Cargill, MD, PhD - MD Anderson Cancer Center, Houston -
09:25am - 09:30am ET
AARS1/2-Mediated Histone Lactylation Drives an Immunosuppressive Tumor Microenvironment and Represents a Novel Target to Enhance Anti-PD-1 Therapy
Speaker: Mei Liu, - Cancer Center, Shandong University, Jinan -
09:30am - 09:35am ET
Radiotherapy under Low Glucose Triggers Disulfidptosis in SLC7A11-High Tumors by Limiting Pentose Phosphate Pathway-Derived NADPH
Speaker: Mengyao Su, - Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan -
09:35am - 09:55am ETSpeaker: David Yu, MD, PhD - Emory University, Atlanta
-
09:55am - 10:00am ETSpeaker: Kent Mouw, MD, PhD - Dana-Farber Cancer Institute, Boston